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Summary statement 
 Pharmacological and genetic manipulations show that endogenous serotonin inhibits 
axonal regeneration of individually identifiable descending neurons of lampreys after a 
complete spinal cord injury. 
Abstract 
 Classical neurotransmitters are mainly known for their roles as neuromodulators, but 
they also play important roles in the control of developmental and regenerative processes. 
Here, we used the lamprey model of spinal cord injury to study the effect of serotonin in axon 
regeneration at the level of individually identifiable descending neurons. Pharmacological 
and genetic manipulations after a complete spinal cord injury showed that endogenous 
serotonin inhibits axonal regeneration in identifiable descending neurons through the 
activation of serotonin 1A receptors and a subsequent decrease in cAMP levels. RNA 
sequencing revealed that changes in the expression of genes that control axonal guidance 
could be a key factor on the serotonin effects during regeneration. This study provides new 
targets of interest for research in non-regenerating mammalian models of traumatic CNS 
injuries and extends the known roles of serotonin signalling during neuronal regeneration. 
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Introduction 
 In contrast to mammals, including humans, lampreys recover locomotion 
spontaneously following a complete spinal cord injury (SCI; see Barreiro-Iglesias, 2012, 
2015; Rodicio and Barreiro-Iglesias, 2012; Sobrido-Cameán and Barreiro-Iglesias, 2018). In 
lampreys, the process of recovery from SCI involves a positive astroglial response 
(Fernández-López et al., 2014), the production of new neurons in the spinal cord (Zhang et 
al., 2014) and the regeneration of ascending and descending axons through the injury site 
(Yin and Selzer, 1983; Davis and McClellan, 1994; Jacobs et al., 1997; Cornide-Petronio et 
al., 2011). This regeneration is specific in that axons grow selectively in their normal 
directions (Yin and Selzer, 1983; Yin et al., 1984; Mackler et al., 1986). Moreover, 
regenerated axons of descending brain neurons are able to re-establish synaptic connections 
with their appropriate targets below the site of injury (Mackler and Selzer, 1987; Oliphint et 
al., 2010). However, in lampreys not all descending neurons of the brain are able to 
regenerate their axons following a complete spinal cord transection, even when normal 
appearing locomotor function is observed several weeks after the injury (Davis and 
McClellan, 1994; Jacobs et al., 1997). Approximately, 50% of all descending brainstem 
neurons are able to regenerate their axon below the site of injury after a complete SCI (Cohen 
et al., 1986; Oliphint et al., 2010). Among brain descending neurons, the brainstem of 
lampreys contains several giant individually identifiable descending neurons that vary greatly 
in their regenerative ability, even when their axons run in similar paths in a spinal cord that is 
permissive for axonal regrowth (Jacobs et al., 1997). Some identifiable neurons like the 
Mauthner or I1 neurons regenerate their axon less than 10% of the times after a complete 
spinal cord transection, while other identifiable neurons like the I3 or B6 neurons are able to 
regenerate their axon more than 60% of the times after a complete SCI (Jacobs et al., 1997). 
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This suggests that intrinsic factors present in some neurons, but not in others, might limit 
their regenerative ability. Lampreys offer a convenient vertebrate model in which to study the 
inhibition or promotion of axonal regeneration after SCI in the same in vivo preparation. 
One of the molecules known to be a key intrinsic regulator of axonal regeneration is 
the second messenger cyclic-adenosine monophosphate (cAMP) (see Hannila and Filbin, 
2008; Hao et al., 2016). Several reports in mammals and fishes have shown that cAMP 
promotes axon regeneration following SCI (Neumann et al., 2002; Qiu et al., 2002; Bhatt et 
al., 2004; Nikulina et al., 2004; Pearse et al., 2004). Subsequent studies have also shown that 
cAMP promotes axon regeneration in descending neurons of lampreys after SCI (Jin et al., 
2009; Lau et al., 2013; Pale et al., 2013). The challenge now is to define the signals that 
control cAMP levels in descending neurons after axotomy and during regeneration. 
Several neurotransmitters modulate intracellular cAMP levels by activating 
metabotropic G-protein coupled receptors, which include serotonin (5-HT), glutamate, 
GABA or dopamine receptors. So, neurotransmitters acting through these receptors are 
potential regulators of intracellular cAMP levels following a traumatic injury to the CNS. 
Among them, 5-HT appears as a good candidate to regulate axon regeneration following 
nervous system injuries (see Sobrido-Cameán et al., 2018). 5-HT receptors are divided in 7 
families, with families 1, 2 and 4 to 7 being G-protein coupled metabotropic receptors and 
type 3 5-HT receptors being ligand-gated ion channels. Families 1 and 5 of 5-HT receptors 
are known to decrease intracellular levels of cAMP; whereas, families 4, 6 and 7 increase 
intracellular levels of cAMP. A few in vitro studies have shown that 5-HT inhibits axon 
regrowth in invertebrate (Murrain et al., 1990; Koert et al., 2001) and vertebrate (Lima et al., 
1994, 1996) species. In contrast, a recent study in Caenorhabditis elegans showed that 5-HT 
promotes axon regeneration after axotomy (Alam et al., 2016). However, no study has yet 
looked at the role of 5-HT in axon regeneration in a in vivo vertebrate model of traumatic 
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CNS injury. The existence of rich 5-HT innervation in the vicinity of descending neurons of 
the lamprey brainstem (Antri et al., 2006; Abalo et al., 2007; Antri et al., 2008; Barreiro-
Iglesias et al., 2008), the expression of 5-HT1A receptors in identifiable descending neurons 
of lampreys (Cornide-Petronio et al., 2013), electrophysiological data showing that 
descending neurons of lampreys are modulated by 5-HT (Antri et al., 2008) and data showing 
an increase in synaptic contacts on descending neurons following SCI in lampreys (Lau et al., 
2011) prompted us to study the possible role of 5-HT in axon regeneration following SCI in 
lampreys. Here, we present gain and loss of function data, using pharmacological and genetic 
treatments, showing that endogenous 5-HT inhibits axon regeneration in identifiable 
descending neurons of lampreys following a complete SCI by activating 5-HT1A receptors. 
We also performed an RNA sequencing study, which revealed that changes in the expression 
of genes that control axonal guidance could be a key factor on the 5-HT effects during 
regeneration. This provides a new target of interest for SCI research in non-regenerating 
mammalian models. 
 
Results 
A 5-HT treatment inhibits axon regeneration in identifiable descending neurons after a 
complete SCI 
To reveal the effect of 5-HT in the regeneration of identifiable descending neurons, 
larval sea lampreys were treated with the 5-HT analogue 5-HT-hydrochloride for a month 
following a complete spinal cord transection. At 11 weeks post-lesion (wpl), the 5-HT 
treatment significantly inhibited axon regeneration of identifiable descending neurons of the 
sea lamprey (Student’s t-test, p = 0.0145; Fig. 1A-C). Importantly, behavioural analyses 
revealed that the 5-HT treatment did not cause a general toxic effect since locomotor 
recovery was not affected by the 5-HT treatment (Fig. 1D). 
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 cAMP treatment can reverse the inhibitory effect of 5-HT on axonal regeneration 
Previous studies have shown that a single dose of cAMP applied at the time of 
transection promotes axon regeneration of identifiable descending neurons following a 
complete spinal cord transection in larval sea lampreys (Jin et al., 2009; Lau et al., 2013; Pale 
et al., 2013). Here, and to reveal a possible involvement of this second messenger in the 
inhibitory effect of 5-HT in axonal regeneration, we carried out a rescue experiment in which 
animals treated with 5-HT as above were also treated with dibutyryl-cAMP (db-cAMP). The 
db-cAMP treatment was able to significantly rescue the inhibitory effect of 5-HT, with these 
animals reaching levels of axonal regeneration of identifiable descending neurons similar to 
control vehicle treated animals (ANOVA, p = 0.0288, Fig. 1A-C). 
 
Serotonergic system and identifiable descending neurons after SCI 
 Previous studies showed the presence of rich serotonergic innervation in the vicinity 
of descending neurons in the brainstem of lampreys and that the activity of these neurons is 
modulated by 5-HT (see introduction). Here, we carried out 5-HT immunofluorescence 
experiments combined with tracer labelling from the site of a complete SCI. We also 
observed the presence of rich serotonergic innervation in close proximity to the injured 
identifiable descending neurons (see an example in Fig. S1). So, identifiable descending 
neurons can receive endogenous 5-HT signalling after a complete SCI. 
The 5-HT1A receptor is an ancient G-protein coupled receptor that is known to 
decrease intracellular cAMP levels through Gi/Go when activated by 5-HT. In a previous 
study, we showed that this receptor is expressed in identifiable descending neurons of larval 
sea lampreys (Cornide-Petronio et al., 2013). This, together with the results of the db-cAMP 
treatments (see previous section) prompted us to study whether there was a correlation 
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between the expression of the 5-HT1A receptor in identifiable descending neurons and their 
known regenerative ability following a complete spinal cord transection. We carried out in 
situ hybridization analyses in horizontal sections of the sea lamprey brain to look at the 
expression of the 5-HT1a receptor in individually identifiable neurons. This, as opposed to 
whole-mounts, impedes the clear identification of all identifiable descending neurons in all 
sections; therefore, in these analyses only the M1, M2, M3, I1 and I3 neurons where 
included. 
 Our in situ hybridization experiments revealed that in bad regenerator neurons 
(neurons that regenerate their axon less than 30% of the times) there is a significant increase 
in the expression of the 5-HT1A receptor 4 weeks after a complete SCI (M2 neuron: Kruskal-
Wallis, p = 0.0105; M3 neuron: ANOVA, p = 0.0478; I1 neuron: ANOVA, p = 0.0238; Fig. 
2A; Table 1), while in good regenerator neurons (M1 and I3 neurons) the expression of the 
receptor decreases (non-significantly) in the first weeks following a complete spinal cord 
transection (Fig. 2B; Table 1). Statistical analyses revealed a significant correlation between 
the percentage of increase/decrease in the expression of the receptor at 4 wpl and the long-
term regenerative ability of identifiable neurons (Pearson’s test, p = 0.0293, Fig. 2C). These 
data, together with the 5-HT immunofluorescence results, suggest that the presence and 
activity of the 5-HT1A receptor in descending neurons might inhibit axonal regeneration 
after a complete SCI. 
 
Endogenous 5-HT inhibits axon regeneration through the 5-HT1A receptor following SCI 
  Based on the immunofluorescence and in situ hybridization results, we decided to 
study whether endogenous 5-HT inhibits axon regeneration of identifiable descending 
neurons by activating 5-HT1A receptors. For this, we treated animals for 4 weeks after a 
complete spinal cord transection with the 5-HT1A receptor antagonist WAY-100,135. The 
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WAY-100,135 treatment significantly promoted axon regeneration 11 wpl in identifiable 
neurons compared to control vehicle treated animals (Student’s t-test, p = 0.049, Fig. 3A-C). 
This indicates that endogenous 5-HT inhibits axon regeneration following a complete SCI by 
activating 5-HT1A receptors. The WAY-100,135 treatment did not significantly change the 
behavioural recovery of the animals (Ayer’s test: control: 5.875  0.125; WAY-100,135: 
5.875  0.081; Mann Whitney U test test, p > 0.9999; not shown); although, this was 
expected since control animals already reach the highest degrees of recovery (5 to 6). 
 To confirm that the inhibitory effect of endogenous 5-HT is due to the activation of 5-
HT1A receptors expressed in identifiable descending neurons we decided to specifically 
knock-down the expression of the receptor in these neurons by using morpholinos targeted 
against the translation initiation site of the 5-HT1A receptor (Fig. S2A). The morpholinos 
were applied at the time of transection on the rostral stump of the spinal cord. Fluorescent 
labelling of the morpholinos confirmed that these were retrogradely transported and reached 
the soma of descending neurons during the first wpl (Fig. S2B). Immunohistochemical 
analyses revealed that at 4 wpl the application of the morpholino targeting the translation 
initiation site significantly reduced the expression of the 5-HT1A receptor in reticulospinal 
neurons of the sea lamprey brainstem as compared to the standard control morpholino 
(Student’s t-test, p = 0.001; Fig. S2C, D). More importantly, and as expected from the 
antagonist treatments, the application of this morpholino significantly promoted axon 
regeneration of identifiable neurons following a complete spinal cord transection as 
compared to the animals that received the standard control morpholino (Mann Whitney U 
test, p = 0.0177, Fig. 3D-F). A second morpholino targeting the 5’ untranslated region of the 
5-HT1a mRNA (non-overlapping with the first morpholino) was used as a control of 
specificity (Fig. S2A). The application of this second morpholino also significantly promoted 
axon regeneration of identifiable neurons (Student’s t-test, p = 0.0342; Fig. S2E). Both the 
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antagonist and morpholino treatments indicate that endogenous 5-HT inhibits axon 
regeneration in identifiable neurons after SCI by activating 5-HT1A receptors expressed in 
these neurons. 
 
 
The WAY-100,135 treatment increases cAMP levels in the brainstem 
 To study whether changes in cAMP levels might be behind the beneficial effects of 
the 5-HT1A receptor antagonist treatment, another set of animals was treated with WAY-
100,135 for 1 week. A cAMP detection assay of the whole-brainstem revealed that the 
antagonist treatment, which also promoted axonal regeneration (see previous section), 
significantly increased cAMP levels in the brainstem (Mann-Whitney U test, p = 0.0397; Fig. 
3G). This result indicates that the inhibition of axon regeneration caused by the activation of 
5-HT1A receptors by endogenous 5-HT might be caused by a decrease in intracellular levels 
of cAMP. 
 
RNA sequencing following a WAY-100,135 treatment reveals new signalling pathways 
possibly involved in axonal regeneration in lampreys 
 Our gain and loss of function experiments revealed that endogenous 5-HT inhibits 
axon regeneration following SCI in the sea lamprey through the activation of 5-HT1A 
receptors and that this effect might be caused by a decrease in intracellular cAMP levels. To 
reveal new genes that might be involved in the intrinsic control of axon regeneration and 
whose expression is modulated by the activity of 1A receptors we decided to repeat the 
WAY-100,135 treatment and carry out an RNA sequencing study in the sea lamprey 
brainstem at 4 wpl. 
A total of 61 differentially expressed genes were detected between WAY-100,135 
treated samples and control vehicle treated animals (Figure 4A, Table S1). Most of these 
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genes were found down-regulated after the WAY-100,135 treatment (5 up-regulated genes, 
56 down-regulated). Among these down-regulated genes in response to WAY-100,135 is 
Plexin-B1 (PLXNB1, logFC = -0.42), which plays a role in axon guidance and works as a 
transmembrane receptor for semaphorins (Driessens et al., 2002). Only one of the five 
significantly up-regulated genes was annotated, Glutamine synthetase (GLUL, logFC = 1.05). 
This gene is primarily found in astrocytes and protects neurons against excitotoxicity (Suarez 
et al., 2002). Pathway analysis using Reactome (Fabregat et al., 2018) revealed 29 
significantly enriched pathways (FDR p-value < 0.05; Table S2). Among these, the most 
interesting ones are “Axon guidance”, “Signalling by ROBO receptors” and “Regulation of 
expression of SLITs and ROBOs”, which are represented only by down-regulated genes. 
Since this RNA sequencing analysis was performed using the whole brainstem, which 
contains both descending and non-descending neurons, we decided to confirm the expression 
of one of the “Axon guidance” genes, Plexin-B1, in descending neurons. 
Immunofluorescence experiments revealed the presence of intense Plexin-B1 
immunoreactivity in the soma (Fig. 4B) and axons (Fig. 4C) of identifiable descending 
neurons, which confirms that these neurons can be a direct target of 5-HT signalling after 
SCI. 
 
Discussion 
 We have provided gain and loss of function evidence, using pharmacological and 
genetic treatments, showing that endogenous 5-HT inhibits axon regeneration after SCI in 
lampreys by activating 5-HT1A receptors expressed in descending neurons. Our results also 
suggest that differential changes in 5-HT1A receptor expression in descending neurons could 
be one of the factors that explain the different regenerative abilities of individual descending 
neurons. 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
 Only a few studies have previously looked at the possible role of 5-HT in neurite/axon 
regeneration and these have been carried out only in invertebrate and in vitro models (see 
Sobrido-Cameán et al., 2018). Koert and co-workers (2001) showed that in the snail Lymnaea 
stagnalis auto-released 5-HT inhibited neurite outgrowth in cultured serotonergic cerebral 
giant cells. An ex vivo study in the pond snail (Helisoma trivolis) showed that the 
spontaneous regeneration of specific neurons was inhibited by 5-HT treatments (Murrain et 
al., 1990). 5-HT or 5-HT reuptake inhibitor treatments also inhibited neurite outgrowth from 
goldfish retinal explants with a previous crush to the optic nerve (Lima et al., 1994, 1996). 
So, our results confirm these previous in vitro studies and show that endogenous 5-HT 
inhibits axon regeneration after a traumatic injury in vivo and in a vertebrate species. The 
only exception to these results comes from a recent study showing that in the nematode 
Caenorhabditis elegans 5-HT promotes axon regeneration (Alam et al., 2016). In these 
animals, non-serotonergic neurons temporarily express tryptophan hydroxylase (the rate-
limiting enzyme in 5-HT synthesis) in response to axotomy promoting their regeneration 
(Alam et al., 2016). We should consider that 5-HT can signal through a variety of 5-HT 
receptors that activate different secondary pathways. In our study, the db-cAMP co-treatment 
rescued the inhibitory effects of the 5-HT treatment (see above). This effect of db-cAMP 
could be additive and independent of 5-HT, but our results using a 5-HT1A receptor 
antagonist indicate that in lampreys the negative effect of endogenous 5-HT on the 
regeneration of descending neurons is caused by the activation of 5-HT1A receptors and a 
subsequent reduction in cAMP levels. Previous in vitro studies in goldfish also showed that 
the activation of 5-HT1A receptors inhibits neurite outgrowth (Lima et al., 1994; Schmeer et 
al., 2001). Accordingly, 5-HT1A agonist treatments reduced neurite outgrowth from retinal 
explants of goldfish with a prior crush of the optic nerve (Lima et al., 1994; Schmeer et al., 
2001). Interestingly, in C. elegans the opposite effect of 5-HT was mediated by the activation 
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of 5-HT 7 receptors, since mutations of this receptor caused defects in axon regeneration after 
axotomy (Alam et al., 2016). Notably, Alam and co-workers (2016) showed that the positive 
effect of the activation of this receptor was caused (at least partially) by the stimulation of 
adenylate cyclase to produce cAMP. Taken together, present and previous results indicate 
that 5-HT is an important regulator of axon regeneration by modulating cAMP levels and that 
the effects of 5-HT will depend on the preferential use of different types of 5-HT receptors in 
different neurons. 
Our RNA sequencing study also revealed changes in gene expression in the brainstem 
associated to 5-HT1A receptor signalling after a complete SCI. Of interest, a treatment with a 
5-HT1A receptor antagonist (which increases cAMP levels and promotes axon regeneration) 
reduced the expression of some genes associated to the regulation of axonal guidance. 
Specifically, Plexin-B1 was one of the most significantly downregulated genes together with 
the pathways “Axon guidance”, “Signalling by ROBO receptors” and “Regulation of 
expression of SLITs and ROBOs”. Interestingly, previous work in lampreys has suggested 
that the expression/activity of some receptors that participate in axonal guidance inhibits 
axonal regeneration after SCI in identifiable neurons (e.g. UNC5: Shifman and Selzer, 2000; 
Barreiro-Iglesias et al., 2012; Chen et al., 2017). Also, a previous study already suggested a 
possible involvement of semaphorin/plexin signalling in recovery after SCI in lampreys 
based on the occurrence of changes in the expression of semaphorins in the spinal cord after 
the injury (Shifman and Selzer, 2007). Future studies should functionally test the possible 
involvement of Slits and semaphorins in the inhibition of axonal regeneration in descending 
neurons after SCI in lampreys. 
Present and previous work in regenerating species shows that 5-HT plays different 
roles in the process of regeneration after SCI. In zebrafish, endogenous 5-HT promotes motor 
neuron production in the spinal cord after a complete SCI by enhancing the proliferation of 
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motor neuron progenitor cells (Barreiro-Iglesias et al., 2015). In turtles, 5-HT inhibits the 
emergence of serotonergic interneurons after SCI by inhibiting a change in neurotransmitter 
phenotype of non-serotonergic neurons (Fabbiani et al., 2018). On the other hand, the 
production of new-born serotonergic neurons in the spinal cord of zebrafish after SCI is not 
affected by endogenous 5-HT (Barreiro-Iglesias et al., 2015). Here, our results show that in 
regenerating vertebrates endogenous 5-HT also controls axon regeneration of descending 
neurons after SCI. These studies suggest that 5-HT could be a target of interest in non-
regenerating mammalian models of SCI, since it can modulate several aspects of the 
regenerative process. Even more importantly, the effects of 5-HT revealed in these studies 
should be consider by those authors performing pharmacological treatments with 
serotonergic drugs to modulate spinal cord circuits aiming to promote locomotor recovery 
after SCI (see Becker and Parker, 2015), mainly because these treatments could be affecting 
the regeneration of new neurons or the re-growth of axotomized axons as shown here. 
 
Materials and Methods 
Animals 
 All experiments involving animals were approved by the Bioethics Committee at the 
University of Santiago de Compostela and the Consellería do Medio Rural e do Mar of the 
Xunta de Galicia (license reference JLPV/IId; Spain) and were performed in accordance to 
European Union and Spanish guidelines on animal care and experimentation. During the 
experimental procedures, special effort was taken to minimize animal suffering and to reduce 
the use of animals. Animals were deeply anaesthetized with 0.1% MS-222 (Sigma, St. Louis, 
MO) in lamprey Ringer solution before all experimental procedures and euthanized by 
decapitation at the end of the experiments. 
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Mature and developmentally stable larval sea lampreys, Petromyzon marinus L. (n = 
191; between 90 and 120 mm in body length, 5 to 7 years of age), were used in the study. 
Larval lampreys were collected from the river Ulla (Galicia, north-western Spain), with 
permission from the Xunta de Galicia, and maintained in aerated fresh water aquaria at 15 °C 
with a bed of river sediment until their use in experimental procedures. Larval lampreys were 
randomly distributed between the different experimental groups. 
 
 
Spinal cord injury surgical procedures 
Larval sea lampreys were assigned to the following experimental groups: control 
animals without a complete spinal cord transection or animals with a complete spinal cord 
transection that were analysed 1 wpl, 4 wpl or 11 wpl. Within some of the 4 wpl and 11 wpl 
groups the animals were assigned to either a vehicle treated control group or to a treatment 
group. Table 2 summarizes the number of animals assigned to each experimental group. Each 
experiment was carried out in at least 2 different batches of animals. Complete spinal cord 
transections were performed as previously described (Barreiro-Iglesias et al., 2014). Briefly, 
the spinal cord was exposed from the dorsal midline at the level of the 5th gill by making a 
longitudinal incision with a scalpel (#11). A complete spinal cord transection was performed 
with Castroviejo scissors and the spinal cord cut ends were visualized under the 
stereomicroscope. Then, the animals were kept on ice for 1 hour to allow the wound to air 
dry. After this hour, the animals were returned to fresh water tanks and each transected 
animal was examined 24 hours after surgery to confirm that there was no movement caudal to 
the lesion site. Then, the animals were allowed to recover in fresh water tanks at 19.5 ºC and 
in the dark. 
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 Drug treatments 
 The following drugs were used to treat the animals following the complete spinal cord 
transection: 5-HT-hydrochloride (a 5-HT analogue that crosses the blood brain barrier; 
AlfaAesar; Cat: B21263; MW: 212.68 g/mol), WAY-100,135 (a 5-HT1A receptor 
antagonist that crosses the blood brain barrier; Sigma; Cat: W1895; MW: 468.46 g/mol) and 
db-cAMP (Sigma; Cat: D0260; MW: 491.37 g/mol). 5-HT-hydrochloride was applied at a 
concentration of 500 µM in the water were the animals were left after the surgical 
procedures. Controls were left in fresh water only. Animals were treated with 5-HT-
hydrochloride for 4 wpl changing the water and the drug twice per week. WAY-100,135 was 
dissolved in lamprey Ringer’s solution (137 mMNaCl, 2.9 mMKCl, 2.1 mM CaCl2, 2 mM 
HEPES; pH 7.4) and injected intraperitoneally at a concentration of 1 mM (volume of 25 µl 
per injection). Vehicle injections served as a control. Animals were treated with WAY-
100,135 for 1 or 4 wpl receiving 1 intraperitoneal injection per week. Dd-cAMP was also 
dissolved in lamprey Ringer’s solution at a concentration of 100 mM, soaked in a small piece 
of Gelfoam (Pfizer; New York, NY) and placed on top of the site of injury at the time of 
transection as previously described by other authors (Jin et al., 2009; Lau et al., 2013). 
Gelfoam soaked in the same volume of lamprey Ringer’s solution served as a control. 
We assumed that these drugs also crossed the blood brain barrier in lampreys as in 
mammals, since the blood brain barrier of lampreys is similar to that of higher vertebrates 
(Bundgaard, 1982; Bundgaard and van Deurs, 1982). 5-HT was applied at the same 
concentration previously used by other authors (Becker and Parker, 2015).  Becker and 
Parker (2015) already reported that this concentration of 5-HT affects the swimming 
behaviour of lesioned and unlesioned animals indicating that this application route allows 
access to the CNS. We also observed changes in the swimming behaviour of unlesioned 
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animals in pilot experiments using WAY-100,135 at this concentration (not shown). For db-
cAMP application we followed the protocol used by other authors in lampreys in studies in 
which this treatment promoted axonal regeneration after SCI (Jin et al., 2009; Lau et al., 
2013). 
 
5-HT immunofluorescence combined with retrograde tract-tracing 
Immunofluorescence experiments were carried out to confirm the presence of 
serotonergic innervation in the vicinity of injured identifiable neurons of 1 wpl animals. The 
retrograde tracer Neurobiotin (NB, 322.8 Da molecular weight; Vector Labs, Burlingame, 
CA) was applied on the rostral end of the transected spinal cord with the aid of a minute pin 
(#000). The animals were allowed to recover at 19 ºC with appropriate ventilation conditions 
for 1 week to allow transport of the tracer from the application point to the soma of 
descending neurons.  
For immunohistochemistry, the brains of larvae were fixed by immersion in 4% PFA 
in 0.05 M Tris-buffered saline pH 7.4 (TBS) for 4 hours at 4 ºC. The samples were then 
rinsed in TBS, cryoprotected with 30% sucrose in TBS, embedded in Tissue Tek (Sakura), 
frozen in liquid nitrogen-cooled isopentane, and cut serially on a cryostat (14 µm thickness) 
in transverse planes. Sections were mounted on Superfrost® Plus glass slides (Menzel). 
Then, the sections were incubated with a rabbit polyclonal anti-5-HT antibody (dilution 
1:2,500; Immunostar, Still Water, MN; Cat#: 20080; lot 431001; RRID: AB_572263; 
immunogen: 5-HT-formaldehyde-BSA conjugate) at room temperature overnight. The 
primary antibody was diluted in TBS containing 15% normal goat serum and 0.2% Triton X-
100 as detergent. The sections were rinsed in TBS and incubated for 1 hour at room 
temperature with a Cy3-conjugated goat anti-rabbit antibody (1:200; Millipore; Burlington, 
MA). Then, the sections were incubated at room temperature with Avidin D-FITC conjugated 
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(Vector; Cat#: A-2001; 1:1,000) diluted in TBS containing 0.3% Triton X-100 for 4 hr to 
reveal the presence of Neurobiotin. Slides were rinsed in TBS and distilled water and 
mounted with Mowiol.  
The specificity of the anti-5-HT antibody was tested by the supplier, who reported no 
detectable cross-reactivity with tryptamine, 5-methoxytryptamine, L-tryptophan, 5-
hydroxytryptophan, dopamine, norepinephrine or adrenaline. The 5-HT antibody was tested 
by western blot of sea lamprey brain extracts in our laboratory (Villar-Cerviño et al., 2006). 
No protein band was detected in these blots. Moreover, immunostaining of sections was 
completely abolished after pre-adsorption of the anti-5-HT antibody with 5-HT-BSA 
conjugates (Abalo et al., 2007). 
 
In situ hybridization 
For 5-HT1a receptor in situ hybridization, the head of the animals was fixed by 
immersion in 4% paraformaldehyde (PFA) in 0.05 M Tris-buffered saline (TBS; pH 7.4) for 
12 hours. Then, the brains were dissected out, washed and embedded in Neg 50TM (Microm 
International GmbH, Walldorf, Germany), frozen in liquid nitrogen-cooled isopentane, 
sectioned on a cryostat in the horizontal plane (14 μm thick) and mounted on Superfrost Plus 
glass slides (Menzel, Braunschweig, Germany). In situ hybridization with a specific 
riboprobe for the 5-HT1a receptor (GenBank accession number KU314442.1) was conducted 
as previously described (Cornide-Petronio et al., 2013, 2014). Briefly, brain sections were 
incubated with the sea lamprey 5-HT1a receptor DIG-labelled probe at 70 ºC and treated with 
RNAse A (Invitrogen, Massachusetts, USA) in the post-hybridization washes. Then, the 
sections were incubated with a sheep anti-DIG antibody conjugated to alkaline phosphatase 
(1:2000; Roche, Mannhein, Germany) overnight. Staining was conducted in BM Purple 
(Roche) at 37ºC. In situ hybridization experiments were performed in parallel with animals 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
from the different experimental groups (control, 1 wpl and 4 wpl) and the colorimetric 
reaction was stopped simultaneously for all sections from the different groups of animals. 
 
Morpholino treatments 
The spinal cord was transected at the level of the 5th gill (see surgical procedures), 
and 1 µl of the morpholinos (0.25 mM in Milli-Q-water) were applied on the rostral stump of 
the spinal cord. The morpholinos were designed by GeneTools, LLC (Philomath, OR) and 
included 2 fluorescein conjugated active translation-blocking 5-HT1A receptor morpholinos 
(first 5-HT1A receptor morpholino: 5’ - CTGTGATGTTGTGAGCTTCCATCG - 3’; second 
5-HT1A receptor morpholino: 5’ - CGCTCGTCTTTGTGTGGA - 3’) generated against the 
translation initiation region of the sea lamprey 5-HT1A receptor sequence (Fig. S2A) and the 
fluorescein conjugated GeneTools standard control morpholino (5’- 
CCTCTTACCTCAGTTACAATTTATA - 3’). During recovery, the morpholinos are 
retrogradely transported to the cell soma of descending neurons where they can knockdown 
the expression of the target mRNA (Fig. S2B; Zhang et al., 2015; Fogerson et al., 2016; Chen 
et al., 2017; Hu et al., 2017; Romaus-Sanjurjo et al., 2018). The GeneTools standard control 
morpholino has been already used in previous studies using morpholino treatments after SCI 
in lampreys (Zhang et al., 2015; Hu et al., 2017). Animals were allowed to recover for 1, 4 or 
11 wpl. 
Immunofluorescence experiments were carried out as above (for 5-HT 
immunofluorescence) to confirm that the active 5-HT1A receptor morpholino decreases the 
expression of the sea lamprey receptor. In these experiments, the sections were incubated 
with a rabbit polyclonal anti-5-HT1A receptor antibody (dilution 1:200; Abcam; Cambridge, 
UK; Cat#: ab85615; lot GR318082-1; RRID: AB_10696528; immunogen: synthetic peptide 
corresponding to rat 5-HT1A receptor amino acids 100-200 conjugated to keyhole limpet 
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haemocyanin) at room temperature overnight. 0.2% Tween was used as a detergent in these 
experiments. Amino acids 100 to 200 of the rat receptor show an 87% correspondence with 
the same region of the sea lamprey 5-HT1A receptor. Moreover, immunostaining of sea 
lamprey sections was abolished after pre-adsorption of the anti-5-HT1A receptor antibody 
with the synthetic peptide (Fig. S2F). 
 
Behavioural analyses 
The behavioural recovery of the animals treated with 5-HT-hydrochloride or WAY-
100,135 was analysed at 11 wpl based on the study of Ayers (Ayers, 1989) and following the 
protocol of Hoffman and Parker (2011) before tracer application. This qualitative assessment 
of locomotor function was made from video recordings of 5 minutes (camera: Panasonic 
Full-HD HC-V110). The animals were placed in a plastic aquarium (36 x 23 x 10.5 cm) and 
swimming activity was initiated by lightly pinching the tail of the animal using a pair of 
forceps. Locomotor recovery of the animals was categorized in a scale of 1 to 6 (Ayers, 1989; 
Hoffman and Parker, 2011). Animals in stage 5 or 6 correspond to animals in which 
regeneration of axons through the site of injury has occurred based on activity evoked by 
stimulation across the lesion site in the isolated spinal cord (Hoffman and Parker, 2011). Two 
blinded experimenters independently evaluated each 11 wpl animal. Based on both analyses, 
a mean value of locomotor recovery was obtained for each animal. 
 
Retrograde labelling of regenerated descending neurons 
At 11 wpl a second complete spinal cord transection was performed 5 mm below the 
site of the original transection and the retrograde tracer Neurobiotin (Vector) was applied in 
the rostral end of the transected spinal cord with the aid of a minute pin (#000). The animals 
were allowed to recover at 19 ºC with appropriate ventilation conditions for 1 week to allow 
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transport of the tracer from the application point to the neuronal soma of descending neurons 
(the M1, M2, M3, I1, I2, I3, I4, I5, I6, B1, B2, B3, B4, B5, B6, Mth and Mth’ neurons were 
analysed; Fig. S3). Since the original SCI also was a complete spinal cord transection, only 
neurons whose axons regenerated at least 5 mm below the site if injury were labelled by the 
tracer. Brains of these larvae were dissected out, and the posterior and cerebrotectal 
commissures of the brain were cut along the dorsal midline, and the alar plates were deflected 
laterally and pinned flat to a small strip of Sylgard (Dow Corning Co., USA) and fixed with 
4% PFA in TBS for 4 hours at 4 ºC. After washes in TBS, the brains were incubated at 4 ºC 
with Avidin D-FITC conjugated (Vector; Cat#: A-2001; 1:500) diluted in TBS containing 
0.3% Triton X-100 for 2 days to reveal the presence of Neurobiotin. Brains were rinsed in 
TBS and distilled water and mounted with Mowiol. 
 
Assay for the quantification of cAMP concentration 
 cAMP concentration in the brainstem of animals treated with WAY-100,135 was 
analysed 1 wpl using a quantitative cAMP competitive ELISA kit (Invitrogen, Waltham, MA, 
USA; Cat#: EMSCAMPL) following the manufacturer’s instructions. This assay is based on 
the competition between cAMP in the standard or sample and alkaline phosphatase 
conjugated cAMP for a limited amount of cAMP monoclonal antibody bound to an anti-
rabbit IgG precoated 96-well plate. The brains of larvae were dissected out 1 hour after the 
second WAY-100,135 or control intraperitoneal injections and immediately homogenized in 
0.1 M HCl on ice. 
 
RNA sequencing 
 Animals treated during 4 wpl with WAY-100,135 and control vehicle treated animals 
were processed for an RNA sequencing analysis of the whole brainstem. The brainstems of 
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larvae were dissected out and immediately put in RNAlater® (Ambion Inc.). RNA extraction 
was performed using the RNeasy mini kit (Qiagen) with DNase treatment following 
manufacturer’s instructions. RNA quality and quantity were evaluated in a Bioanalyzer 
(Bonsai Technologies) and in a NanoDrop® ND-1000 spectrophotometer (NanoDrop® 
Technologies Inc), respectively. Three WAY-100,123 and three control samples (each 
sample containing 4 brainstems) were barcoded and prepared for sequencing by the 
Wellcome Trust Centre for Human Genetics (Oxford, UK) using standard protocols. 
Sequencing was conducted on an Illumina HiSeq 2000 as 100 bp paired-end reads. Raw 
sequencing has been deposited in NCBI’s Short Read Archive (SRA) under BioProject 
accession PRJNA472778. The quality of the sequencing output was assessed using FastQC 
v.0.11.5. (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Quality filtering and 
removal of residual adaptor sequences was conducted on read pairs using Trimmomatic 
v.0.35 (Bolger et al., 2014). Specifically, residual Illumina specific adaptors were clipped 
from the reads, leading and trailing bases with a Phred score less than 20 were removed and 
the read trimmed if a sliding window average Phred score over four bases was less than 20. 
Only reads where both pairs had a length greater than 36 bp post-filtering were retained. A de 
novo transcriptome was assembled using Trinity v.2.4.0 (Grabherr et al., 2011) with default 
settings. Gene expression was estimated using Kallisto v.0.43.1 (Bray et al., 2016) and 
statistical analyses related to differential expression were performed using R v.3.4.3 (R Core 
Team 2014). Gene count data were used to estimate differential gene expression using the 
Bioconductor package DESeq2 v.3.4 (Love et al., 2014). The Benjamini-Hochberg false 
discovery rate (FDR) was applied, and transcripts with corrected p-values < 0.05 were 
considered differentially expressed genes. Heatmaps were drawn using the R package 
“gplots” v.3.01.1 (Gregory et al., 2016). Pathway analyses were performed using Reactome 
(Fabregat et al., 2018), converting all non-human gene identifiers to their human equivalents. 
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Immunofluorescence experiments were carried out as above (for 5-HT) to confirm 
Plexin-B1 expression in descending neurons of the sea lamprey. In these experiments, the 
transverse sections of the brain and spinal cord were incubated with a rabbit polyclonal anti-
Plexin-B1 antibody (dilution 1:100; Developmental Studies Hybridoma Bank; Iowa, USA; 
Cat#: PCRP-PLXNB1-3A7; RRID: AB_2618961; immunogen: human Plexin-B1) at room 
temperature overnight. The alignment of the partial sea lamprey Plexin-B1 protein sequence 
and the human Plexin-B1 protein sequence shows 41% of amino acidic identities and 60% of 
positive amino acidic positions. 
 
Imaging and quantifications 
The percentage of neurons with regenerated axons (labelled by the Neurobiotin tracer) 
respect to the total number of analysed neurons (see Table 1) was calculated for each type of 
identifiable descending neuron using an Olympus microscope. The percentage of neurons 
with regenerated axons respected to the total number of analysed neurons in each animal was 
also calculated and these data was used for statistical analyses. The experimenter was blinded 
during quantifications. For the figures, images were taken with a spectral confocal 
microscope (model TCS-SP2; Leica). 
An Olympus photomicroscope (AX-70; Provis) with a 20x Apochromatic 0.75 lens 
and equipped with a colour digital camera (Olympus DP70, Tokyo, Japan) was used to 
acquire images of brain sections from the in situ hybridization experiments. Images were 
always acquired with the same microscope and software settings. The quantification of the 
level of 5-HT1a receptor positive signal in identifiable descending neurons was performed as 
previously described (Romaus-Sanjurjo et al., 2018). First, we established the intensity rank 
of positive colorimetric in situ signal. For this, we analysed 10 random images from different 
descending neurons of control and lesioned animals. The “histogram” function in Image J 
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shows the number of pixels in each image in a range of intensity from 0 to 255. With these 
images, we compared the intensity values in regions with clear in situ signal and the intensity 
values in regions without in situ signal. Based on this, we established a value of 179 as the 
lower limit to consider the colorimetric in situ signal as positive. Then the number of pixels 
of positive in situ signal was quantified for each section of each identified descending neuron. 
In horizontal brain sections, the identification of some of the specific descending cells 
becomes more difficult than in whole-mounts. Thus, only the cells that were unequivocally 
identified in at least two different sections were included in the quantifications (the M1, M2, 
M3, I1 and I3 neurons; see Fig. S3). Then, we calculated the average number of positive 
pixels per section for each individual neuron (see Table 1) and this data was used for 
statistical analyses. The experimenter was blinded during quantifications. 
For the quantification of changes in 5-HT1A receptor immunoreactivity after 
morpholino application, 3 14-µm transverse sections of the medial reticular nucleus of the 
rhombencephalon were analysed in each animal. 1 out of every 2 consecutive sections in the 
next 6 sections caudally to the last section where the Mauthner neuron was observed were 
analysed in each animal. The mean fluorescence intensity of each section was calculated 
using Image J and then the mean fluorescence intensity per section in each animal was used 
for the statistical analyses. 
After quantifications, contrast and brightness were minimally adjusted with Adobe 
Photoshop CS6 (Adobe Systems, San José, CA, USA). Figure plates and lettering were 
generated using Adobe Photoshop CS6 (Adobe Systems). Schematic drawing was generated 
using CorelDraw Graphics Suite 2017. 
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 Statistical analyses 
Statistical analysis was carried out using Prism 6 (GraphPad software, La Jolla, CA). 
Data were presented as mean ± S.E.M. Normality of the data was determined by the 
Kolmogorov-Smirnov test or the D'Agostino-Pearson omnibus test. The data from the db-
cAMP treatments and the in situ hybridization data that were normally distributed were 
analysed by a one-way ANOVA. Post-hoc Dunnett´s multiple comparison tests were used to 
compare pairs of data. In situ hybridization data that were not normally distributed were 
analysed by a Kruskal-Wallis test and post-hoc Dunn’s multiple comparisons test. A 
Student’s t-test was used to determine significant differences between conditions in the qPCR 
analysis. The results of control versus treatment groups were analysed by a Student’s t-test 
(normally distributed data) or Mann Whitney U test (non-normally distributed data). The 
significance level was set at 0.05. In the figures, significance values were represented by a 
different number of asterisks in the graphs: 1 asterisk (p value between 0.01 and 0.05) and 2 
asterisks (p value between 0.001 and 0.01). Exact p values are given in the text. 
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Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. A 5-HT treatment inhibits axonal regeneration of identifiable 
descending neurons and an additional cAMP treatment rescues the inhibitory effect of 
5-HT. A: Photomicrographs of whole-mounted brains showing regenerated identifiable 
neurons, as identified by retrograde labelling, in control, 5-HT treated and 5-HT and cAMP 
treated animals. Note the decreased number of labelled (regenerated) identifiable neurons in 
5-HT treated animals. B: Graph showing the percentage of regenerated neurons (respect to 
the total number of analysed neurons) for each identifiable descending neuron in control, 5-
HT treated and 5-HT and cAMP treated animals. Arrows indicate identifiable descending 
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neurons that regenerated in control or 5-HT and cAMP treated animals, but not in 5-HT 
treated animals. Rostral is up and the midline to the left in all photomicrographs. Scale bars: 
100 µm. C: Graph showing significant changes (asterisks) in the percentage of identifiable 
regenerated neurons per animal after the 5-HT or 5-HT and cAMP treatments (control: 57.06 
 3.08 %; 5-HT: 40.56  5.74 %; 5-HT + cAMP: 57.51  4.39 %). D: Graph showing non-
significant differences in recovery of swimming behaviour (Ayers’ test) in control and 5-HT 
treated animals (Ayer’s test score: control: 5.70  0.15; 5-HT treated: 5.50  0.22).  
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Figure 2. Changes in the expression of the 5-HT1a receptor in identifiable 
descending neurons after a complete SCI. A: Graphs and photomicrographs showing 
significant changes (asterisk) in the number of 5-HT1a positive in situ pixels per section of 
the soma of bad regenerator identifiable descending neurons. The mean ± S.E.M. values are 
provided in table 2. B: Graphs and photomicrographs showing changes in the number of 5-
HT1a positive in situ pixels per section of the soma of good regenerator identifiable 
descending neurons. The mean ± S.E.M. values are provided in table 2. Examples of 
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photomicrographs of horizontal sections of control and injured identifiable descending 
neurons are shown to the right of the graphs in A and B. The somas of identifiable neurons 
are outlined in the photomicrographs. The location of these neurons in the sea lamprey brain 
can be observed in Fig. S3. Scale bars: 20 µm. C: Linear regression analysis showed an 
inverse relation between the percentage of change in 5-HT1a transcript expression at 4 wpl 
and regeneration probability (from Jacobs et al., 1997) of each cell (95% confidence intervals 
for slope = -0.08298 ± 0.0211; Sy.x = 13.23). 
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Figure 3. WAY-100,135 or 5-HT1A MO treatments promote axonal regeneration 
of identifiable descending neurons. A: Photomicrographs of whole-mounted brains 
showing regenerated identifiable neurons, as identified by retrograde labelling, in control and 
WAY-100,135 treated animals. Note the increased number of labelled (regenerated) 
identifiable neurons in WAY-100,135 treated animals. B: Graph showing significant changes 
(asterisk) in the percentage of regenerated neurons per animal after the WAY-100,135 
treatment (control: 44.05  5.58 %; WAY-100,135: 59.16  6.44 %). C: Graph showing the 
percentage of regenerated neurons (respect to the total number of analysed neurons) for each 
identifiable cell in control and WAY-100,135 treated animals. D: Photomicrographs of 
whole-mounted brains showing regenerated identifiable neurons, as identified by retrograde 
labelling, in control and 5-HT1A MO treated animals. Note the increased number of labelled 
(regenerated) identifiable neurons in 5-HT1A MO treated animals. E: Graph showing 
significant changes (asterisk) in the percentage of regenerated neurons per animal after the 5-
HT1A MO treatment (control: 53.69  4.97 %; 5-HT1A MO: 68.29  4.12 %). F: Graph 
showing the percentage of regenerated neurons (respect to the total number of analysed 
neurons) for each identifiable cell in control and 5-HT1A MO treated animals. G: Graph 
showing significant changes (asterisk) in cAMP concentration per milligram of brainstem in 
control and WAY-100,135 treated animals (control: 1.594  125.4 pmol of cAMP/mg of 
brainstem; WAY-100,135: 1.878  81.74 pmol of cAMP/mg of brainstem). Arrows indicate 
descending neurons that regenerated in WAY-100,135 or 5-HT1A MO treated animals but 
not in controls animals. Rostral is up in all photomicrographs. The midline is to the right in 
photomicrographs of control animals and to the left in photomicrographs of treated animals. 
Scale bars: 100 µm. 
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Figure 4. The WAY-100,135 treatment causes changes in gene expression. A: 
Heatmap showing the expression of 61 differentially expressed genes between samples 
treated with WAY-100,135 and control samples in RNA sequencing. Gene expression is 
represented as regularized log-transformed read counts scaled by gene. Samples (x-axis) and 
genes (y-axis) were hierarchically clustered according to their gene expression Euclidian 
distances using complete linkage clustering. B: Photomicrograph of a transverse section of 
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the sea lamprey brain showing the presence of intense Plexin-B1 immunoreactivity in the M2 
neuron. C: Photomicrograph of a transverse section of the sea lamprey spinal cord showing 
the presence of Plexin-B1immunoreactivity in descending axons (arrows). The asterisks 
indicate the ventricle (B) and central canal (C). Dorsal is to the top. The plane of section of 
these photomicrographs can be observed in Fig. S3. Scale bars: 100 µm. 
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Tables 
Table 1. Mean ± S.E.M. values of the number of 5-HT1a positive in situ pixels per 
section in identifiable descending neurons of control and injured animals.  
Refers to Fig. 2. 
 
5-HT1a positive 
pixels/section 
Control 1 wpl 4 wpl 
M1 118,053±28,907 69,944±29,647 47,977±23,429 
M2 12,188±4,609 22,354±11,186 73,734±28,394 
M3 17,981±7,496 74,329±28,886 136,996±52,416 
I1 9,367±5,697 15,864±10,099 19,685±8,690 
I3 52,673±20,947 7,698±3,587 19,714±10,667 
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 Table 2. Table showing the number of animals included in each experimental group 
and also the total number of identifiable descending neurons that were included in the 
analyses.  
Note that in the in situ hybridization experiments only the neurons that were 
unequivocally identified in at least 2 brain sections were included in the quantifications. 
 
 
 
  Total number of neurons included in the analyses 
 
 
Animals M1 M2 M3 I1 I2 I3 I4 I5 I6 B1 B2 B3 B4 B5 B6 Mth Mth' 
5-HT + cAMP 
treatments 
(11 wpl) 
Control 10 19 19 19 11 17 20 20 16 19 20 18 20 20 19 19 20 20 
5-HT 
treated 
6 11 11 11 11 11 12 12 11 8 12 12 12 12 12 12 11 10 
5-HT + 
cAMP 
treated 
10 19 19 18 18 18 20 19 11 13 20 19 19 20 20 19 18 19 
5-HT 
immunofluorescence + 
Neurobiotin labelling 
Control 2 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
5-HT1a in situ 
hybridization 
Control 6 11 10 10 8 /// 7 /// /// /// /// /// /// /// /// /// /// /// 
1 wpl 5 7 5 10 8 /// 5 /// /// /// /// /// /// /// /// /// /// /// 
4 wpl 5 7 6 6 7 /// 6 /// /// /// /// /// /// /// /// /// /// /// 
WAY-100,135 
treatment 
(11 wpl) 
Control 8 14 14 14 15 14 15 15 9 4 14 11 14 15 9 13 14 14 
Treated 8 12 13 13 14 10 11 9 5 3 15 12 15 14 13 11 13 11 
5-HT1A MO 
treatment 
(11 wpl) 
Control 10 19 18 19 17 17 19 19 14 12 22 22 22 22 22 22 22 22 
Treated 7 13 13 13 13 13 14 14 9 11 14 14 14 14 14 14 14 14 
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5-HT1A MO 
retrograde transport 
(1 wpl) 
Control 2 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
Treated 2 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
5-HT1A MO 2 
treatment 
(11 wpl) 
Control 14 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 
Treated 13 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 
5-HT1A 
immunohistochemistry 
(MO treated, 4 wpl) 
Control 5 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
Treated 6 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
5-HT1A 
immunohistochemistry 
(Pre-adsorption) 
Control 3 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
Pre-
adsorpted 
3 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
cAMP assay 
(1 wpl) 
 
Control 20 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
Treated 20 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
RNA-seq 
(4 wpl) 
 
Control 12 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
Treated 12 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
Plexin-B1 
immunofluorescence 
Control 2 /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// /// 
 
TOTAL 191 
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Figure S1. 5-HT innervation of identifiable descending neurons after SCI. A-A’’: 
Photomicrographs of a transverse section of the sea lamprey midbrain showing the 
presence of rich serotonergic innervation (in red) in the vicinity of the M3 neuron 
(labelled with Neurobiotin in green). B-B’’: Orthogonal reconstruction of a detail of the 
region indicated with a square in A-A’’ showing a serotonergic fibre in very close 
proximity (see overlapping of both channels in yellow) to a dendrite of the M3 neuron. 
The asterisks indicate the ventricle. Dorsal is to the top. The plane of section can be 
observed in Fig. S3. Scale bar: 100 µm. 
Disease Models & Mechanisms: doi:10.1242/dmm.037085: Supplementary information
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Figure S2. 5-HT1A receptor morpholinos. A: Partial sequence of the sea lamprey 5-
HT1a receptor with exon sequence in red and 5’ untranslated sequence in black. The 
target sequence of the first 5-HT1A MO is between square brackets (see Fig. 3D-F). The 
target sequence of the second 5-HT1A MO is underlined. The ATG initiation codon is 
indicated between parenthesis. B: Photomicrograph of a whole-mounted brain showing 
the presence of the first 5-HT1A MO in identifiable neurons 1 week after the MO 
application at the site of SCI. C: Photomicrographs of transverse sections of the 
brainstem showing 5-HT1A immunoreactivity in control and 5-HT1A MO treated 
animals. Note the decreased immunoreactivity in reticulospinal neurons of 5-HT1A MO 
treated animals. The asterisks indicate the ventricle. Dorsal is to the top in all 
photomicrographs. The plane of section of these photomicrographs can be observed in 
Fig. S3. D: Graph showing significant changes (asterisks) in the mean fluorescence 
intensity of 5-HT1A immunoreactivity per section in reticulospinal nuclei of the 
brainstem after the 5-HT1A MO treatment. E: Graph showing significant changes 
(asterisk) in the percentage of regenerated neurons per animal after the treatment with 
the second 5-HT1A MO (control: 56.51 ± 3.02 %; 5-HT1A MO 2: 65.84 ± 2.83 %). F: 
Photomicrographs of transverse sections of the brainstem showing 5-HT1A 
immunoreactivity in control and in anti-5-HT1A antibody pre-adsorption experiments. 
Note the lack of immunoreactivity in reticulospinal neurons after antibody pre-
adsorption. The asterisks indicate the ventricle. Dorsal is to the top in all 
photomicrographs. The plane of section of these photomicrographs can be observed in 
Fig. S3. Scale bars: 100 µm. 
Disease Models & Mechanisms: doi:10.1242/dmm.037085: Supplementary information
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
Figure S3. Schematic drawing of a dorsal view of the sea lamprey brainstem 
showing the location of identifiable descending neurons (modified from 
Sobrido-Cameán and Barreiro-Iglesias, 2018). The approximate plane of section of Fig. 
4B is shown in black. The approximate plane of section of Fig. S1 is shown in green. The 
approximate plane of section of Figs. S2C and E is shown in blue. The approximate plane 
of section of Fig. 4C is shown in red. Abbreviations: M: mesencephalon; R: 
rhombencephalon; SC: spinal cord. Rostral is up. 
Disease Models & Mechanisms: doi:10.1242/dmm.037085: Supplementary information
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Supplementary Tables 
Table S1. Differentially expressed genes between control and WAY-100,135 treated 
samples. 
List of genes showing significant differential expression (FDR p-value < 0.05) between 
control samples and samples treated with WAY-100,135. Gene expression level 
(average normalized count values), log2 fold change (positive values represent up-
regulation in response to WAY-100,135 treatment), FDR corrected p-value, Uniprot ID 
of the most significant blast hit, blast alignment length, blast alignment identity 
percentage, blast alignment E value, protein name of the most significant blast hit, gene 
symbol of the most significant blast hit and species of the most significant blast hit are 
shown for every differentially expressed gene. 
Table S2. Results of the Reactome pathway analysis. 
List of Reactome pathways showing significant enrichment (FDR p-value < 0.05) for 
the list of differentially expressed genes between control and WAY-100,135 treated 
samples. Pathway name, total genes assigned to the pathway, total genes present in the 
pathway and FDR corrected p-value are shown for every enriched Reactome pathway. 
Click here to Download Table S1 
Click here to Download Table S2 
Disease Models & Mechanisms: doi:10.1242/dmm.037085: Supplementary information
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